HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Stabilization of physical RAF/14-3-3 interaction by cotylenin A as treatment strategy for RAS mutant cancers.

Abstract
One-third of all human cancers harbor somatic RAS mutations. This leads to aberrant activation of downstream signaling pathways involving the RAF kinases. Current ATP-competitive RAF inhibitors are active in cancers with somatic RAF mutations, such as BRAF(V600) mutant melanomas. However, they paradoxically promote the growth of RAS mutant tumors, partly due to the complex interplay between different homo- and heterodimers of A-RAF, B-RAF, and C-RAF. Based on pathway analysis and structure-guided compound identification, we describe the natural product cotylenin-A (CN-A) as stabilizer of the physical interaction of C-RAF with 14-3-3 proteins. CN-A binds to inhibitory 14-3-3 interaction sites of C-RAF, pSer233, and pSer259, but not to the activating interaction site, pSer621. While CN-A alone is inactive in RAS mutant cancer models, combined treatment with CN-A and an anti-EGFR antibody synergistically suppresses tumor growth in vitro and in vivo. This defines a novel pharmacologic strategy for treatment of RAS mutant cancers.
AuthorsManuela Molzan, Stefan Kasper, Lars Röglin, Malgorzata Skwarczynska, Takeshi Sassa, Takatsugu Inoue, Frank Breitenbuecher, Junko Ohkanda, Nobuo Kato, Martin Schuler, Christian Ottmann
JournalACS chemical biology (ACS Chem Biol) Vol. 8 Issue 9 Pg. 1869-75 (Sep 20 2013) ISSN: 1554-8937 [Electronic] United States
PMID23808890 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • 14-3-3 Proteins
  • Biological Products
  • Diterpenes
  • cotylenin A
  • Proto-Oncogene Proteins c-raf
  • raf Kinases
  • ras Proteins
Topics
  • 14-3-3 Proteins (metabolism)
  • Animals
  • Biological Products (pharmacology, therapeutic use)
  • Cell Line, Tumor
  • Diterpenes (pharmacology, therapeutic use)
  • Humans
  • Mice
  • Mice, SCID
  • Models, Molecular
  • Neoplasms (drug therapy, genetics)
  • Protein Interaction Maps (drug effects)
  • Proto-Oncogene Proteins c-raf (metabolism)
  • raf Kinases (genetics, metabolism)
  • ras Proteins (genetics)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: